Anxiety and mood (대한불안의학회지)

Korean Academy of Anxiety Disorders (대한불안의학회)
권호 표지

The Significance of Affective Problems in Obsessive-Compulsive Disorder

강박장애에서 정서 이상의 의미

  • 황성식 (보령 엘피스병원) ;
  • 노대영 (연세대학교 의과대학 정신과학교실) ;
  • 김찬형 (연세대학교 의과대학 의학행동과학연구소)
  • Received : 2009.10.20
  • Accepted : 2010.03.26
  • Published : 2010.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Researchers consider obsessive-compulsive disorder (OCD) to be an anxiety disorder, but it often shows comorbidity with other disorders in the affective spectrum. Epidemiological and clinical studies have shown a strong association between OCD and mood disorders. In addition, some reports show the patients with OCD have attentional-processing impairments regarding emotional information. However, research has not revealed the exact nature and degree to which OCD constitutes an affective problem. In this review, we discuss the affective aspects of OCD and the relationship between OCD and mood disorders.

Keywords

References

  1. Gorman JM, Liebowitz MR, Fyer AJ, Dillon D, Davies SO, Stein J, et al. Lactate infusions in obsessive-compulsive disorder. Am J Psychiatry 1985;142:864-866. https://doi.org/10.1176/ajp.142.7.864
  2. E B. Lehrbuch der Psychiatrie. Springer-Verlag, Berlin;1920.
  3. Jaisoorya TS, Janardhan Reddy YC, Srinath S. Is juvenile obsessivecompulsive disorder a developmental subtype of the disorder?--Findings from an Indian study. Eur Child Adolesc Psychiatry 2003;12: 290-297. https://doi.org/10.1007/s00787-003-0342-2
  4. Farid NR. Understanding the genetics of autoimmune thyroid disease-- still an illusive goal! J Clin Endocrinol Metab 1992;74:495A-495B. https://doi.org/10.1210/jc.74.3.495a
  5. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank, E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004;161:2222-2229. https://doi.org/10.1176/appi.ajp.161.12.2222
  6. Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res 1995;59:57-64. https://doi.org/10.1016/0165-1781(95)02752-1
  7. Hantouche EG, Angst J, Demonfaucon C, Perugi G, Lancrenon S, Akiskal HS. Cyclothymic OCD: a distinct form? J Affect Disord 2003; 75:1-10. https://doi.org/10.1016/S0165-0327(02)00461-5
  8. Unoki K, Kasuga T, Matsushima E, Ohta K. Attentional processing of emotional information in obsessive-compulsive disorder. Psychiatry Clin Neurosci 1999;53:635-642. https://doi.org/10.1046/j.1440-1819.1999.00618.x
  9. Sprengelmeyer R, Young AW, Pundt I, Sprengelmeyer A, Calder AJ, Berrios G, et al. Disgust implicated in obsessive-compulsive disorder. Proc Biol Sci 1997;264:1767-1773. https://doi.org/10.1098/rspb.1997.0245
  10. Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am 1992;15:743-758.
  11. Kendell RE DW. Obsessional symptoms and obsessional personality traits in patients with depressive illnesses. Br J Psychiatry 1980;136: 1-25. https://doi.org/10.1192/bjp.136.1.1
  12. Abramowitz JS, Storch EA, Keeley M, Cordell E. Obsessive -compulsive disorder with comorbid major depression: what is the role of cognitive factors? Behav Res Ther 2007;45:2257-2267. https://doi.org/10.1016/j.brat.2007.04.003
  13. Angst J, Dobler-Mikola A. The Zurich Study. VI. A continuum from depression to anxiety disorders? Eur Arch Psychiatry Neurol Sci 1985; 235:179-186. https://doi.org/10.1007/BF00380990
  14. Hantouche EG, Demonfaucon C, Angst J, Perugi G, Allilaire JF, Akiskal HS. [Cyclothymic obsessive-compulsive disorder. Clinical characteristics of a neglected and under-recognized entity]. Presse Med 2002;31:644-648.
  15. Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci 2004;254:156-164.
  16. Holma KM, Melartin TK, Holma IA, Isometsa ET. Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5-year prospective study. J Clin Psychiatry 2008;69: 1267-1275. https://doi.org/10.4088/JCP.v69n0809
  17. Frost RO, Steketee G, Williams LF, Warren R. Mood, personality disorder symptoms and disability in obsessive compulsive hoarders: a comparison with clinical and nonclinical controls. Behav Res Ther 2000;38:1071-1081. https://doi.org/10.1016/S0005-7967(99)00137-0
  18. Wheaton M, Timpano KR, Lasalle-Ricci VH, Murphy D. Characterizing the hoarding phenotype in individuals with OCD: associations with comorbidity, severity and gender. J Anxiety Disord 2008;22:243-252. https://doi.org/10.1016/j.janxdis.2007.01.015
  19. Whiteside SP, Abramowitz JS. Obsessive.compulsive symptoms and the expression of anger. Cognitive Therapy and Research 2004;28: 259-268. https://doi.org/10.1023/B:COTR.0000021544.64104.29
  20. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004; 132:69-79. https://doi.org/10.1016/j.pscychresns.2004.07.001
  21. Radomsky AS, Ashbaugh AR, Gelfand LA. Relationships between anger, symptoms, and cognitive factors in OCD checkers. Behav Res Ther 2007;45:2712-2725. https://doi.org/10.1016/j.brat.2007.07.009
  22. Perugi G, Akiskal HS, Pfanner C, Presta S, Gemignani A, Milanfranchi A, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord 1997; 46:15-23. https://doi.org/10.1016/S0165-0327(97)00075-X
  23. Hasler G, LaSalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D, et al. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res 2005;135:121-132. https://doi.org/10.1016/j.psychres.2005.03.003
  24. Tukel R, Meteris H, Koyuncu A, Tecer A, Yazici O. The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2006;256:240-245. https://doi.org/10.1007/s00406-006-0632-z
  25. Corcoran KM, Woody SR, Tolin DF. Recognition of facial expressions in obsessive-compulsive disorder. J Anxiety Disord 2008;22:56-66. https://doi.org/10.1016/j.janxdis.2007.01.003
  26. Montagne B, de Geus F, Kessels RP, Denys D, de Haan EH, Westenberg HG. Perception of facial expressions in obsessive-compulsive disorder: a dimensional approach. Eur Psychiatry 2008;23:26-28. https://doi.org/10.1016/j.eurpsy.2007.07.007
  27. Salkovskis PM. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther 1985;23:571-583. https://doi.org/10.1016/0005-7967(85)90105-6
  28. Parker HA, McNally RJ, Nakayama K, Wilhelm S. No disgust recognition deficit in obsessive-compulsive disorder. J Behav Ther Exp Psychiatry 2004;35:183-192. https://doi.org/10.1016/j.jbtep.2004.04.008
  29. Bozikas VP, Kosmidis MH, Giannakou M, Saitis M, Fokas K, Garyfallos G. Emotion perception in obsessive-compulsive disorder. J Int Neuropsychol Soc 2009;15:148-153. https://doi.org/10.1017/S1355617708090097
  30. Foa EB, Ilai D, McCarthy PR, Shoyer B, Murdock T. Information processing in obsessive-compulsive disorder. Cogn Ther Res 1993;17: 173-189. https://doi.org/10.1007/BF01172964
  31. Seok JH, Kim JJ, Jeon JH, Lee HS, Lee E, Kim CH. Characteristics of Emotional Information Processing in Patients with chronic obsessive compulsive disorder : comparison with schizophrenia and healthy controls. J Korean Neuropsychiatr Assoc 2005;44:311-318.
  32. Mandal MK, Bhattacharya BB. Recognition of facial affect in depression. Percept Mot Skills 1985;61:13-14. https://doi.org/10.2466/pms.1985.61.1.13
  33. Wood SR, Tolin DF. The relationship between disgust sensitivity and avoidant behavior: studies of clinical and nonclinical samples. J Anxiety Disord 2002;16:543-559. https://doi.org/10.1016/S0887-6185(02)00173-1
  34. Phillips ML, Young AW, Senior C, Brammer M, Andrew C, Calder AJ, et al. A specific neural substrate for perceiving facial expressions of disgust. Nature 1997;389:495-498. https://doi.org/10.1038/39051
  35. Aigner M, Sachs G, Bruckmuller E, Winklbaur B, Zitterl W, Kryspin- Exner I, et al. Cognitive and emotion recognition deficits in obsessivecompulsive disorder. Psychiatry Res 2007;149:121-128. https://doi.org/10.1016/j.psychres.2005.12.006
  36. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000;23: 563-586. https://doi.org/10.1016/S0193-953X(05)70181-7
  37. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, et al. Cerebral glucose metabolism in childhood-onset obsessive- compulsive disorder. Arch Gen Psychiatry 1989;46:518-523. https://doi.org/10.1001/archpsyc.1989.01810060038007
  38. Baxter LRJr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, et al. Cerebral glucose metabolic rates in nondepressed pa-tients with obsessive-compulsive disorder. Am J Psychiatry 1988;145:1560-1563. https://doi.org/10.1176/ajp.145.12.1560
  39. Bench CJ, Friston KJ, Brown RG, Frackowiak RS, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993;23:579-590. https://doi.org/10.1017/S0033291700025368
  40. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628-3641.
  41. Biver F, Goldman S, Delvenne V, Luxen A, De Maertelaer V, Hubain P, et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994;36:381-388. https://doi.org/10.1016/0006-3223(94)91213-0
  42. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 2004;43:1146-1153. https://doi.org/10.1097/01.chi.0000132812.44664.2d
  43. Spinella M. Mood in relation to subclinical obsessive-compulsive symptoms. Int J Neurosci 2005;115:433-443. https://doi.org/10.1080/00207450590522838
  44. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46: 243-250. https://doi.org/10.1001/archpsyc.1989.01810030049007
  45. Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 2001;50:159-170. https://doi.org/10.1016/S0006-3223(01)01123-4
  46. Cardoner N, Soriano-Mas C, Pujol J, Alonso P, Harrison BJ, Deus J, et al. Brain structural correlates of depressive comorbidity in obsessive- compulsive disorder. Neuroimage 2007;38:413-421. https://doi.org/10.1016/j.neuroimage.2007.07.039
  47. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 1992;53 Suppl: 17-28.
  48. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, et al. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 1992;49:21-28. https://doi.org/10.1001/archpsyc.1992.01820010021003
  49. Kaplan A, Hollander E. A review of pharmacologic treatments for obsessive-compulsive disorder. Psychiatr Serv 2003;54:1111-1118. https://doi.org/10.1176/appi.ps.54.8.1111
  50. Krakowski M. Violence and serotonin: influence of impulse control, affect regulation, and social functioning. J Neuropsychiatry Clin Neurosci 2003;15:294-305. https://doi.org/10.1176/appi.neuropsych.15.3.294
  51. Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004;61:765-773. https://doi.org/10.1001/archpsyc.61.8.765
  52. Bellodi L, Erzegovesi S, Bianchi L, Lucini V, Conca R, Lucca A. Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depression. Psychiatry Res 1997;69:9-15. https://doi.org/10.1016/S0165-1781(96)02961-7
  53. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, et al. Tryptophan depletion in patients with obsessivecompulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 1994;51:309-317. https://doi.org/10.1001/archpsyc.1994.03950040053007
  54. Kulz AK, Meinzer S, Kopasz M, Voderholzer U. Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results. Neuropsychobiology 2007;56:127-131. https://doi.org/10.1159/000115778
  55. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006;59:1151-1159. https://doi.org/10.1016/j.biopsych.2005.09.018
  56. Blier P, Abbott FV. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 2001;26:37-43.
  57. Overbeek T, Schruers K, Vermetten E, Griez E. Comorbidity of obsessive- compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry 2002;63:1106-1112. https://doi.org/10.4088/JCP.v63n1204
  58. Goodman WK, Ward H, Kablinger A, Murphy T. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry 1997;58 (Suppl 5):32-49. https://doi.org/10.4088/JCP.v58n0106e
  59. Blier P, de Montigny C. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol Psychiatry 1998;44:313-323. https://doi.org/10.1016/S0006-3223(98)00114-0
  60. Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, et al. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry 2000;57:76-82. https://doi.org/10.1001/archpsyc.57.1.76
  61. APA practice guideline for MDD in Adults;1993.
  62. Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006;31:2384-2393. https://doi.org/10.1038/sj.npp.1301165
  63. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008;33:368-377. https://doi.org/10.1038/sj.npp.1301408
  64. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-660. https://doi.org/10.1016/j.neuron.2005.02.014
  65. Mundt A, Klein J, Joel D, Heinz A, Djodari-Irani A, Harnack D, et al. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 2009;29:2401-2412. https://doi.org/10.1111/j.1460-9568.2009.06777.x
  66. Greenberg BD, Price LH, Rauch SL, Friehs G, Noren G, Malone D, et al. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin N Am 2003;14:199-212. https://doi.org/10.1016/S1042-3680(03)00005-6